Thursday, November 11, 2021

Covaxin, India’s homegrown COVID jab, ‘highly efficacious’: Study

Data from Phase 3 trials show vaccine offers 78 percent protection against COVID-19, says a study published in Lancet.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)